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Abstract
Accumulation of ubiquitin-positive, tau- and a-synuclein-negative intracellular inclusions of TDP-43 in the central nervous
system represents the major hallmark correlated to amyotrophic lateral sclerosis and frontotemporal lobar degeneration
with ubiquitin-positive inclusions. Such inclusions have variably been described as amorphous aggregates or more
structured deposits having an amyloid structure. Following the observations that bacterial inclusion bodies generally consist
of amyloid aggregates, we have overexpressed full-length TDP-43 and C-terminal TDP-43 in E. coli, purified the resulting full-
length and C-terminal TDP-43 containing inclusion bodies (FL and Ct TDP-43 IBs) and subjected them to biophysical
analyses to assess their structure/morphology. We show that both FL and Ct TDP-43 aggregates contained in the bacterial
IBs do not bind amyloid dyes such as thioflavin T and Congo red, possess a disordered secondary structure, as inferred using
circular dichroism and infrared spectroscopies, and are susceptible to proteinase K digestion, thus possessing none of the
hallmarks for amyloid. Moreover, atomic force microscopy revealed an irregular structure for both types of TDP-43 IBs and
confirmed the absence of amyloid-like species after proteinase K treatment. Cell biology experiments showed that FL TDP-
43 IBs were able to impair the viability of cultured neuroblastoma cells when added to their extracellular medium and, more
markedly, when transfected into their cytosol, where they are at least in part ubiquitinated and phosphorylated. These data
reveal an inherently high propensity of TDP-43 to form amorphous aggregates, which possess, however, an inherently high
ability to cause cell dysfunction. This indicates that a gain of toxic function caused by TDP-43 deposits is effective in TDP-43
pathologies, in addition to possible loss of function mechanisms originating from the cellular mistrafficking of the protein.
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Introduction
TAR DNA-binding protein 43 (TDP-43) is a multifunctional
nuclear protein initially described as a transcription factor [1], but
later found to be also involved in regulation of RNA splicing,
microRNA processing, mRNA transport, stability and translation
[2,3]. In 2006 it was reported, for the first time, that TDP-43 is the
main component of the ubiquitin-positive, tau-negative and a-
synuclein-negative protein inclusions accumulating in the fronto-
temporal cortex and hippocampus of the brain and in the motor
neurons of the spinal cord of patients suffering from frontotem-
poral lobar degeneration with ubiquitin-positive inclusions (FTLD-
U) and amyotrophic lateral sclerosis (ALS) [4]. TDP-43 inclusions
are also found in other neurodegenerative conditions, such as
Alzheimer’s disease and Parkinson’s disease, as well as in inclusion
body myositis and myofibrillar myopathy [5]. However, the
presence of other protein inclusions and clinical manifestations in
all such conditions, and the observation that all TDP-43 mutations
so far discovered are only associated with familial ALS and FTLD-
U, suggest that TDP-43 aggregation is rather a secondary process
in this group of neurodegenerative and muscle diseases [5].
Pathological TDP-43 aggregation is associated with a disloca-
tion of this protein from the nucleus, where the protein normally
resides and plays its functions, to the cytoplasm, where the
inclusions accumulate [4,6,7]. In such cytoplasmic inclusions
TDP-43 is hyperphosphorylated, ubiquitinated and cleaved to
form C-terminal fragments [4,6,7], although in the spinal cord
motor neurons the inclusions consist rather of full-length TDP-43
[8].
The structure of TDP-43 in the inclusions of ALS and FTLD-U
patients is not yet clear and subject of current debate. In
particular, it is not yet clear whether TDP-43 inclusions consist
of amyloid fibrils or rather another type of protein aggregate. In
order to be classified as amyloid, protein aggregates need to
comply with three main criteria that are nowadays accepted by
investigators from different disciplines, from biophysicists to
clinicians: the presence of a fibrillar morphology with the fibrils
having a diameter of typically 7–13 nm, the presence of a cross-b
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secondary structure and the binding to amyloid-diagnostic dyes
like Congo red (CR), thioflavin T (ThT) and thioflavin S (ThS).
Spinal cord sections of ALS patients show the presence of TDP-43
positive, 10–20 nm wide filaments in the absence of CR and ThS
binding, thus suggesting a non-amyloid structure [9–11]. Howev-
er, a very recent report indicates the presence of a widespread
remarkable ThS staining in TDP-43 inclusions present in the
lower motor neurons of sporadic ALS cases, suggesting rather an
amyloid-like structure [12]. In another very recent report, it was
shown that a few TDP-43 inclusions of ALS patients may consist
of 10–20 nm fibrils able to bind ThS, but such features were found
only in a small fraction of skein-like inclusions of the spinal cord,
with amyloid-like characteristics being absent in most spinal cord
skeins and absent altogether in other TDP-43 inclusions of the
spinal cord and in all inclusions of the brain [13].
As far as FTLD-U is concerned, TDP-43 inclusions in the brain
were found to consist of 15–20 nm wide filaments [14]. In another
report, the dentate gyrus of FTLD-U patients was shown to
contain 10–17 nm filaments in intranuclear, cytoplasmic and
neuritic inclusions, with the latter containing filaments that were
randomly oriented [10]. Similarly, filaments with a mean diameter
of 9 nm and 10 nm were found in cytoplasmic and neuritic
inclusions, respectively, of FTLD-U brains, whereas fibrils with a
mean diameter of 18 nm were present in intranuclear inclusions
[15]. Inclusions present in the brain of these patients showed an
inability to bind amyloid-specific dyes [16,17], a finding confirmed
in the spinal cords of FTLD-U patients, where no ThS positive
inclusions were found [13]. However, in the same study showing a
large ThS positivity in ALS spinal cords, a remarkable and diffuse
ThS staining of TDP-43 inclusions in FTLD-U brains was also
reported [12].
Likewise, studies in vitro describing aggregation of purified full-
length or fragmented TDP-43 have reported conflicting reports as
to the structure of the resulting TDP-43 aggregates. In a first
report, full-length TDP-43 was shown to form filaments unable to
bind CR and ThT [18]. By contrast, other reports have shown
that peptides encompassing the most highly aggregating region of
C-terminal TDP-43 are able to form , 10 nm fibrils with b-sheet
secondary structure and dye binding [19–22].
In this work we have addressed this point by overexpressing
full-length and C-terminal TDP-43 in E. coli, purifying the
resulting TDP-43 containing inclusion bodies (FL TDP-43 IBs
and Ct TDP-43 IBs, respectively) and subjecting them to a
number of biophysical analyses to assess their structure and
morphology. Indeed, it is increasingly accepted that bacterial
IBs mainly consist of amyloid-like aggregates [23–28]. There-
fore, the detection of amyloid structure in the TDP-43
aggregates present in FL TDP-43 IBs and Ct TDP-43 IBs
could be informative on the intrinsic propensity of this protein
to form this type of protein aggregate. By contrast, the absence
of amyloid-like structure in bacterial IBs would suggest a
propensity to form another type of deposit. In addition to
performing a biophysical investigation of the TDP-43 IBs, we
have transfected eukaryotic cell cultures with FL TDP-43 IBs to
evaluate their inherent toxicity. We will show that the TDP-43
aggregates contained in the bacterial IBs do not bind ThT and
CR, possess random coil and b-turn secondary structure, and
are highly susceptible to proteinase K (PK) digestion, thus
possessing none of the amyloid distinctive hallmarks. In such
unstructured/amorphous form, however, the FL TDP-43
aggregates appear to be highly toxic when transfected to the
cytosol of the cultured cells, revealing their inherent ability to
cause cell dysfunction.
Materials and Methods
Materials
All reagents were of analytical grade or of the highest purity
available. Amyloid peptide 1–42 (Ab42), Dulbecco’s modified eagle
medium (DMEM), fetal bovine serum (FBS), hen egg white
lysozyme (HEWL), pluronic acid F-127, ampicillin, ThT, CR, PK,
carbobenzoxy-Leu-Leu-leucinal (MG-132), 3-methyladenine (3-
MA), chloroquin and other chemicals were from Sigma-Aldrich,
unless otherwise stated. 29,79-dichlorodihydrofluorescein diacetate
(CM-H2DCFDA; Molecular Probes, Milan, Italy) was prepared as
stock solutions in dimethylsulfoxide (DMSO), dried under nitrogen
and stored in light-protected vessels at 220uC until use. Ab42
oligomers were prepared as previously described [29] and
resuspended in F-12 HAM to different concentrations ranging
from 7.5 mg/mL to 215 mg/mL.
FL and Ct TDP-43 Gene Cloning and Protein Expression
The genes for FL TDP-43 (residues 1–414) and its C-terminal
fragment (residues 208–414) were cloned downstream of the
glutathione S-transferase (GST) gene in the pGEX-2T plasmid. In
brief, the sequence coding for FL TDP-43 and that coding for Ct
TDP-43 were amplified from the pINCY vector (Thermo Fisher
Scientific, Waltham, MA, USA) by PCR, using forward and
reverse primers containing the restriction sites for BamHI and
EcoRI enzymes, respectively. Each amplified sequence and the
pGEX-2T plasmid were digested with BamHI and EcoRI (Thermo
Fisher Scientific) and combined with the T4 DNA ligase (Thermo
Fisher Scientific) to obtain the constructs coding for the GST/FL
TDP-43 and the GST/Ct TDP-43 fusion proteins. Their correct
nucleotide sequence was verified by DNA sequencing.
Cultures of E. coli XL1 Blue cells (Agilent Technologies, Santa
Clara, CA, USA) were transformed with the resulting plasmids
containing FL TDP-43 or Ct TDP-43 and were grown overnight
at 37uC in LB medium with 100 mg/mL ampicillin under vigorous
shaking. Cells were then diluted 1:10 in fresh medium and grown
at 37uC until OD600 nm , 0.6. Protein expression was induced
using 1 mM isopropyl b-D-1-thiogalactoside (IPTG; Inalco, Paris,
France). Cells were harvested by centrifugation, resuspended in
PBS buffer (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4,
1.4 mM KH2PO4, 1 mM EDTA, 1 mM b-mercaptoethanol,
0.1 mM PMSF, at pH 7.3) and then lysed by 30 min incubation
with 1 mg/mL HEWL in ice, followed by sonication at 40 kHz
(five cycles of 30 s each). The expression of FL and Ct TDP-43
and their presence in the supernatant or in the pellet fractions after
cell lysis were checked by SDS-PAGE, using 12% (w/v)
polyacrylamide gels. Wt AcPDro2 IBs and C43S AcPDro2 IBs
were purified and analysed as described in Methods S1.
IBs Purification
IBs were purified from IPTG induced cells harbouring the
pGEX-2T/FL TDP-43 plasmid, the pGEX-2T/Ct TDP-43
plasmid and the only pGEX-2T plasmid by detergent-based
procedures. Briefly, cells obtained from 1 L cultures were
harvested by centrifugation at 290006g for 15 min at 4uC,
resuspended in 40 mL of lysis buffer (50 mM Tris-HCl, 100 mM
NaCl, 1 mM EDTA, at pH 8.0) and maintained overnight at
280uC. After thawing, 35 mL of 100 mM PMSF and 280 mL of
10 mg/mL HEWL were added and the samples were incubated
for 45 min at 37uC under gentle agitation. To cause membrane
lysis, IGEPAL was added to a final concentration of 1% (v/v) and
the mixture was maintained in ice for 1 h under agitation. Then,
600 mL of 1 mg/mL DNase I and 600 mL of 1 M MgSO4 were
added and the resulting mixture was incubated at 37uC for
TDP-43 Aggregates Are Amorphous and Cytotoxic
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40 min. IBs were separated by centrifugation at 290006g for
15 min at 4uC. The resulting IBs were washed once with lysis
buffer containing 0.5% Triton X-100 and twice with water. After a
final centrifugation at 290006g for 15 min at 4uC, the pellet was
stored at 280uC and reconstituted in PBS buffer (137.0 mM
NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, at
pH 7.3).
CR Absorbance
Interaction of CR with IBs was tested using a Jasco V-630
spectrophotometer (Tokyo, Japan) by recording the absorbance
spectra from 400 nm to 700 nm using a 10 mm quartz cell. FL
TDP-43 IBs, Ct TDP-43 IBs and control IBs at 1.0, 1.0 and
0.7 mg/mL concentrations, respectively, were incubated at 25uC
and an aliquot of 60 mL of each sample was mixed with 440 mL of
a 5 mM NaH2PO4, 150 mM NaCl buffer at pH 7.4 containing
20 mM CR. Spectra were then recorded. Spectra were also
recorded for similar samples devoid of CR and similar samples
devoid of IBs. The difference spectrum obtained by subtracting the
spectra of CR alone and IBs alone from that of CR plus IBs
indicated the spectrum of CR bound to b-sheet structure. The CR
spectra obtained for the native HypF-N protein were also recorded
as a further control.
ThT Fluorescence
FL TDP-43 IBs, Ct TDP-43 IBs and control IBs at the same
concentrations described above were incubated at 25uC and an
aliquot of 60 mL of each sample was mixed with 440 mL of a
25 mM NaH2PO4 buffer at pH 6.0 containing 25 mM ThT. The
resulting fluorescence was measured at 25uC using a Perkin-Elmer
LS 55 spectrofluorimeter (Waltham, MA, USA) equipped with a
thermostated cell holder attached to a Haake F8 water bath
(Karlsruhe, Germany), using excitation and emission wavelengths
of 440 and 450–600 nm, respectively. A 2610 mm quartz cuvette
was used. The ThT spectrum obtained in the presence of the same
buffer without IBs was subtracted from those acquired in the
presence of FL TDP-43 IBs, Ct TDP-43 IBs and control IBs. The
ThT fluorescence obtained after incubation with native HypF-N is
reported as a negative control.
Far-UV CD
FL TDP-43 IBs, Ct TDP-43 IBs and control IBs at 2.8, 2.8 and
2.0 mg/mL concentrations, respectively, were prepared in 25 mM
NaH2PO4 buffer at pH 7.3, 25uC. The far-UV circular dichroism
(far-UV CD) spectra were collected over the 190–260 nm
wavelength range at 25uC using a Jasco J-810 Spectropolarimeter
(Tokyo, Japan) equipped with a thermostated cell holder attached
to a Thermo Haake C25P water bath (Karlsruhe, Germany). A
1 mm path-length cell was used. All spectra were blank subtracted.
For the calculation of the molar ellipticity [h] we used the
following formula:
h½ ~ h
10 N0 residues  optical path  concentration
molecular weight
  ð1Þ
were [h] is the molar ellipticity in deg cm2 dmol21, h is the
ellipticity in mdeg, optical path is in cm, concentration is in g/L,
molecular weight is in g/mol.
FTIR
Purified IBs were resuspended in D2O to achieve a final protein
concentration of 21 mg/mL for FL TDP-43 IBs and Ct TDP-43
IBs and 15 mg/mL for control IBs. Each sample was deposited on
a potassium bromide window in a semipermanent liquid cell using
a spacer of 25 mm, and the Fourier transformed infrared
spectroscopy (FTIR) spectrum was recorded at room temperature
using a Jasco FTIR 4200 spectrophotometer (Tokyo, Japan). The
system was constantly purged with N2. The resulting spectra were
background subtracted and baseline corrected.
PK Proteolysis
FL TDP-43 IBs and control IBs were prepared in water at a
final protein concentration of 14.3 mg/mL and 10.0 mg/mL,
respectively, and digested with 250 mg/mL PK at 37uC. The
digestion was followed for 500 s observing the turbidity decrease at
350 nm using a Jasco V-630 spectrophotometer (Tokyo, Japan)
and a 5 mm quartz cell. The digestion kinetics were analysed using
a procedure of best fitting obtained with the following single
exponential equation:
N(t)~kz(N0{ k)e
{lt ð2Þ
where N(t) is the turbidimetry at time t, k is the final value of the
turbidimetry, N0 is the initial turbidimetry, t is the time in s, l is the
rate constant in s21. The FL TDP-43 IBs and Ct TDP-43 IBs
digestions were also followed by SDS-PAGE. The FL TDP-43 IBs
sample at a total protein concentration of 14.3 mg/mL was
treated at 37uC with 250 mg/mL and 20 mg/mL PK, for a total
time of 300 s, while the Ct TDP-43 IBs sample at the same
concentration as FL TDP-43 was treated at 37uC with 20 mg/mL
PK, for a longer time (1200 s). Aliquots of both samples were taken
at defined times and tested by SDS-PAGE using 12% (w/v)
polyacrylamide gels. The progressive FL TDP-43 and Ct TDP-43
digestions were monitored observing the intensity changes of their
corresponding bands.
AFM
Purified IBs were resuspended in water at a protein concentra-
tion of 2 mg/mL and diluted 10 or 100 times. A 10 mL aliquot was
deposited on freshly cleaved mica and dried under mild vacuum.
Digestion with PK was performed by incubating 40 mL of
undiluted IBs with 3.2 mL of a 10 mg/mL PK stock solution for
60 min at 37uC. Digested samples were then diluted 100 times and
a 10 mL aliquot was deposited on freshly cleaved mica and dried
under mild vacuum. Tapping mode atomic force microscopy
(AFM) images were acquired in air using a Dimension 3000 SPM,
equipped with a ‘‘G’’ scanning head (maximum scan size of
100 mm) and driven by a Nanoscope IIIa controller, and a
Multimode SPM equipped with a ‘‘E’’ scanning head (maximum
scan size of 10 mm) and driven by a Nanoscope V controller
(Digital Instruments, Veeco). Single-beam uncoated silicon canti-
levers (type OMCL-AC160TS, Olympus) were used. The drive
frequency was between 260 and 330 kHz; the scan rate was 0.4–
0.8 Hz.
Cell Cultures
Human SH-SY5Y neuroblastoma cells (A.T.C.C., Manassas,
VA) were cultured in DMEM, F-12 HAM with 25 mM HEPES
and NaHCO3 (1:1) and supplemented with 10% FBS, 1 mM
glutamine and antibiotics. Cell cultures were maintained in a 5%
CO2 humidified atmosphere at 37uC and grown until they
reached 80% confluence for a maximum of 20 passages.
Cell Internalisation
FL TDP-43 IBs were labeled with fluorescein-5-isothiocyanate
(5-FITC) using AnaTagTM 5-FITC Microscale Protein Labeling
TDP-43 Aggregates Are Amorphous and Cytotoxic
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Kit (AnaSpec, San Jose, CA, USA). Transfection of both labeled
and unlabeled FL TDP-43 IBs and unlabeled control IBs into SH-
SY5Y neuroblastoma cells was performed using a total protein
concentration of 5.7 mg/mL and 4.0 mg/mL, respectively, and the
PULSin protein delivery reagent (Polyplus-transfection, Illkirch,
France). Cells were also transfected with R-phycoerythrin (R-PE),
a green fluorescent protein used as a positive control (excitation
wavelength was 488 nm). After 3 h transfection, the incubation
medium without serum was replaced with fresh complete medium.
After washing with PBS, cells treated with unlabeled IBs were
counterstained for 10 min with 50 mg/mL Alexa Fluor 633-
conjugated wheat germ agglutinin and fixed in 2% (w/v) buffered
paraformaldehyde for 10 min at room temperature (20uC). After
plasma membrane permeabilisation with a 3% (v/v) glycerol
solution for 5 min, the coverslips were incubated for 60 min with
1:350 diluted rabbit polyclonal anti-TDP-43 antibodies (Sigma-
Aldrich) and then for 90 min with 1:1000 diluted Alexa Fluor 488-
conjugated anti-rabbit antibodies incubated at 37uC. Cells were
analysed using a Leica TCS SP5 confocal scanning microscope
(Leica Microsystems, Mannheim, Germany), equipped with an
argon laser source and a Leica Plan Apo 639 oil immersion
objective.
The colocalization of FL TDP-43 IBs or phosphorylated TDP-
43 with ubiquitin was monitored using 1:350 rabbit polyclonal
anti-TDP-43 antibody or 1:500 rabbit anti-TDP-43 phosphoryla-
tion sites 409/410 (Cosmo Bio Co., Tokio, Japan) for 60 min at
37uC, 1:150 mouse monoclonal anti-ubiquitin antibodies (Life
Technologies, Carlsbad, CA) for 60 min at 37uC, and then with
1:1000 Alexa Fluor 488-conjugated secondary antibodies (Life
Technologies) for 60 min at 37uC and 594-conjugated secondary
antibodies (Life Technologies) for 60 min at 37uC.
MTT Reduction Assay
The toxicity of intracellularly or extracellularly added FL TDP-
43 IBs, control IBs and R-PE was assessed on SH-SY5Y cells
seeded in 96-well plates, 24 h after cell transfection or addition to
the extracellular medium, by the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay as previously described
[30]. The final protein concentrations were 4.0 mg/mL for the cell
internalisation analysis and ranged from 7.5 to 860 mg/mL for the
extracellular analysis (plus 30% for FL TDP-43 IBs). In a set of
experiments, cells were treated with either 5 mM MG-132, 10 mM
3-MA or 40 mM chloroquin, which were added immediately after
cell transfection with FL TDP-43 IBs and control IBs.
Measurement of Intracellular ROS and Caspase-3 Activity
The levels of intracellular ROS production and caspase-3
activity were analysed 24 h after transfection or extracellular
addition of FL TDP-43 IBs and control IBs to SH-SY5Y cells
seeded on glass coverslips and loaded with CM-H2DCFDA, as
previously described [31] and using FAM-FLICATM Caspases
3&7 solution (Caspase 3&7 FLICA kit FAM-DEVDFMK,
Immunochemistry Technologies, Bloomington, MN) [32]. Final
protein concentrations were 4.0 mg/mL and 215 mg/mL (plus
30% for FL TDP-43 IBs) for the intracellular and extracellular
analyses, respectively. Ab42 oligomers at a final protein concen-
tration of 60 mg/mL were also used as a positive control. To
quantify the signal intensity of CM-H2DCFDA, 10–22 cells were
analysed using ImageJ software (NIH, Bethesda, MD), and the
fluorescence intensities were expressed as arbitrary units.
Statistical Analysis
Data were expressed as mean 6 standard deviation (SD).
Comparisons between different groups were performed using
ANOVA followed by Bonferroni’s post-comparison test. A p-value
lower than 0.05 was considered statistically significant. The single
(*), double (**) and triple (***) asterisks refer to p values lower than
0.05, 0.01 and 0.001, respectively.
Results
Aggregation of FL TDP-43 and Ct TDP-43 in IBs of E. coli
Cells
The cDNA encoding FL TDP-43 and Ct TDP-43 were cloned
downstream of the GST gene in the pGEX-2T plasmid. XL1-Blue
cells of E. coli were then transformed with the two resulting
engineered plasmids. To test whether bacterial cells expressed the
fusion GST/FL TDP-43 protein, we evaluated the expression at
37uC with 1 mM IPTG concentration and using SDS-PAGE
(Fig. 1A). The GST/FL TDP-43 band corresponds to a molecular
weight of , 69 kDa, i.e. the sum of the molecular weights of GST
(, 26 kDa) and FL TDP-43 (, 43 kDa). Immediately before
adding IPTG (0 h), a basal protein expression was present. At 2 h
and 4 h from induction a greater quantity of expressed protein was
evident. However, the major expression of the fusion protein was
observed at 16 h. The same conditions were used to evaluate the
bacterial expression of the fusion GST/Ct TDP-43 protein. A
similar expression level to that of the GST/FL TDP-43 protein
was observed by SDS-PAGE, with a band corresponding to a
molecular weight of , 46 kDa, that is the sum of the molecular
weights of GST (, 26 kDa) and Ct TDP-43 (, 20 kDa) (Fig. 1A).
After cell growth for 8 h and protein expression for 16 h at
37uC, the bacteria cells were harvested, lysed and centrifuged and
the resulting supernatant (SN) and pellet (P) were analysed by SDS-
PAGE (Fig. 1B). Both GST/FL TDP-43 and GST/Ct TDP-43
were found entirely in the P fraction indicating that they
precipitated in IBs (Fig. 1B). Bacterial IBs have been shown to
contain amyloid-like aggregates, as determined with CR and ThT
binding, FTIR, X-ray diffraction, AFM and transmission electron
microscopy (TEM) [25,26,28,33–35]. The presence of residual
native-like structures and disordered chain segments has also been
described, their content depending on the particular IB-forming
protein [36–40]. Therefore, bacterial IBs are a physiological
system consisting of several types of protein aggregates, both
amyloid and amorphous, depending on the aggregating proteins.
Thus, the aggregation of GST/FL TDP-43 and GST/Ct TDP-43
into IBs offered the possibility of investigating whether full-length
TDP-43 or its C-terminal fragment have the propensity to form
amyloid or other forms of self-assembly when aggregating in the
highly crowded environment existing in a living organism.
The IBs formed from cells expressing GST/FL TDP-43 (FL
TDP-43 IBs), GST/Ct TDP-43 (Ct TDP-43 IBs) and GST
(control IBs) were purified as described in Materials and Methods.
Using a densitometric analysis of the SDS-PAGE bands we
evaluated that the GST/FL TDP-43 band was 2963% of all
proteins present in FL TDP-43 IBs (Fig. 1C), while the GST/Ct
TDP-43 band was 3262.9% of all proteins present in Ct TDP-43
IBs (Fig. 1C). Therefore, for all the biophysical data present in this
work, we analysed TDP-43 IBs with a total protein concentration
higher than that present in control IBs by, 30%, so that the three
IBs samples contained the same amount of proteins distinct from
TDP-43. Using this approach, it was possible to evaluate the
contribution of TDP-43 relative to other proteins present in IBs by
difference, for example by subtracting the FTIR spectrum of
control IBs from that of FL TDP-43 IBs or from that of Ct TDP-
43 IBs.
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FL TDP-43 and Ct TDP-43 Aggregates do not Bind CR and
ThT
We used the amyloid diagnostic CR dye to assess whether FL
TDP-43 and Ct TDP-43 contained in IBs display typical amyloid
properties. The CR absorbance increased in the presence of FL
TDP-43 IBs and the wavelength of maximum absorption red-
shifted to , 508 nm (Fig. 2A). This spectral change was very
similar to that observed in the presence of control IBs (Fig. 2C).
The CR absorbance increased also in the presence of Ct TDP-43
IBs, although less markedly than in the presence of FL TDP-43
IBs, with a maximum absorption at , 495 nm (Fig. 2B). Spectral
changes of CR were not observed in the presence of native HypF-
N, used here as a soluble protein and, thus, as a negative control
(Fig. 2D). For the three IBs samples, the difference spectrum
obtained subtracting the CR spectrum and the IBs spectrum from
the CR spectrum in the presence of IBs, showed a characteristic
peak at , 550 nm, typical of CR bound to amyloid aggregates
(Fig. 2E). By contrast, the difference spectrum obtained by
subtracting the CR spectrum and the native HypF-N spectrum
from the CR spectrum in the presence of native HypF-N was flat
(Fig. 2E). The observation that the difference spectra obtained
with FL TDP-43 IBs, Ct TDP-43 IBs and control IBs are
superimposable at ,550 nm, indicates that TDP-43 does not
seem to contribute to the amyloid-like structures present in IBs.
We then analysed the capacity of the same samples to bind the
ThT dye and increase its fluorescence. FL TDP-43 IBs increased
the ThT fluorescence less markedly than control IBs, although this
difference was not statistically significant (p.0.05); moreover, Ct
TDP-43 increased the ThT fluorescence similarly to control IBs
(Fig. 2F). Hence, the ThT assay confirms that the FL and Ct TDP-
43 aggregates present in IBs do not have an amyloid-like structure
(Fig. 2F). As expected, no ThT fluorescence increase was observed
in the presence of non-aggregated native HypF-N (Fig. 2F).
As a positive control for E. coli IBs containing amyloid-like
aggregates, we purified IBs formed after expression of the second
acylphosphatase from D. melanogaster (AcPDro2), a protein
previously shown to form amyloid-like fibrils in vitro [41]. In
particular, we purified IBs formed after expression of the
destabilised C43S mutant of the protein (C43S AcPDro2 IBs),
since the wild-type protein was soluble after expression and the
resulting IBs contained little protein (wt AcPDro2 IBs). Unlike the
wt AcPDro2 IBs, the C43S AcPDro2 IBs were found to bind CR,
with a maximum at , 550 nm in the difference spectrum, and to
bind ThT, with a remarkable increase of its fluorescence (Fig. S1).
FL TDP-43 and Ct TDP-43 Aggregates are Composed of a
Random Coil Structure
Amyloid fibrils are closely associated with a b-sheet content that
can be typically detected with either far-UV CD, FTIR or X-ray
fiber diffraction. The CD spectra obtained in the presence of FL
TDP-43 IBs and control IBs display a negative peak at ca. 220–
230 nm and a positive peak at ca. 190–200 nm (Fig. 3A), which is
typical of large aggregates containing amyloid fibrils [42,43]. The
difference spectrum between them discloses the secondary
structure of FL TDP-43 aggregates wherein the presence of a
random coil structure is evident, as shown by a negative peak at ,
198 nm (Fig. 3A). A similar result was obtained with Ct TDP-43
IBs and control IBs, with the CD spectra displaying a negative
peak at , 230 nm and a positive peak below 197 nm (Fig. 3B).
Similarly to the result obtained with FL TDP-43 aggregates, a
largely random coil structure emerges from the difference
spectrum, with a negative peak at ca. 198 nm (Fig. 3B).
Figure 1. FL and Ct TDP-43 expression in E. coli cells. (A) SDS-
PAGE analysis of bacterial proteins at different GST/FL TDP-43 (left) and
GST/Ct TDP-43 (right) induction times (0 h, 2 h, 4 h and 16 h) with
1 mM IPTG at the temperature of 37uC. The band at , 69 kDa indicates
GST/FL TDP-43 (left) and that at , 46 kDa represents GST/Ct TDP-43
(right). (B) SDS-PAGE analysis of total bacterial proteins after GST/FL
TDP-43 (left) and GST/Ct TDP-43 (right) inductions with 1 mM IPTG for
16 h at 37uC and of the P and SN fractions of the same samples after
cell lysis. (C) SDS-PAGE analysis of purified FL TDP-43 IBs, Ct TDP-43 IBs
and control IBs obtained with 1 mM IPTG expression for 16 h at 37uC.
The bands at , 69 kDa and , 46 kDa indicate the GST/FL TDP-43 and
GST/Ct TDP-43 proteins, respectively, that are absent in the control IBs
sample.
doi:10.1371/journal.pone.0086720.g001
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The Amide I regions of FTIR spectra of FL TDP-43 IBs and
control IBs obtained in D2O, as well as their second derivative
spectra, display a prominent peak at , 1650 cm21 corresponding
to a-helix and unordered structures, another peak at ,
1675 cm21 corresponding to b-turn structure and the character-
istic peak at , 1625 cm21 associated with the presence of
intermolecular b-sheet structures (Fig. 3C,E). The difference
spectrum obtained from them shows two major bands at ,
1667 cm21, corresponding to b-turn structure, and , 1640 cm21,
corresponding to unordered structure for an FTIR spectrum
obtained in D2O (Fig. 3C,E). Importantly, the difference spectrum
shows a clear disappearance of the peak in the intermolecular b-
sheet region (Fig. 3C,E), providing further evidence for the lack of
b-sheet structure and presence of disordered structure in the FL
TDP-43 aggregates present in IBs.
The Amide I region of the FTIR spectrum of Ct TDP-43 IBs in
D2O and its second derivative, along with those of control IBs
obtained concomitantly, display a similar peak at , 1650 cm21
associated with a-helix and unordered structures (Fig. 3D,F).
Besides, Ct TDP-43 IBs spectra show a prominent peak at ,
1680 cm21 associated with b-turn structure and a secondary peak
at , 1620 cm21 corresponding to intermolecular b-sheet struc-
tures, while control IBs spectra show the major peak at ,
1620 cm21 indicating the presence of intermolecular b-sheet
structures and a smaller peak at , 1670 cm21 associated with b-
turn structure (Fig. 3D,F). The difference spectrum obtained from
them shows a major peak at , 1680 cm21 associated with b-turn
structure and another smaller peak at , 1645 cm21 correspond-
ing to unordered structure (Fig. 3D,F). Again, the difference
spectrum shows no peaks in the intermolecular b-sheet region,
Figure 2. CR and ThT binding of FL TDP-43 IBs, Ct TDP-43 IBs and control IBs. (A) Absorbance spectra of FL TDP-43 IBs+CR (solid line), CR
(dashed line) and FL TDP-43 IBs (dotted line). (B) Absorbance spectra of Ct TDP-43 IBs+CR (solid line), CR (dashed line) and Ct TDP-43 IBs (dotted line).
(C) Absorbance spectra of control IBs+CR (solid line), CR (dashed line) and control IBs (dotted line). (D) Absorbance spectra of native HypF-N+CR (solid
line), CR (dashed line) and native HypF-N (dotted line). (E) Difference absorbance spectra obtained for FL TDP-43 IBs (green), Ct TDP-43 IBs (red),
control IBs (blue) and native HypF-N (purple). (F) ThT fluorescence spectra in the presence of FL TDP-43 IBs (green), Ct TDP-43 IBs (red), control IBs
(blue) and native HypF-N (purple).
doi:10.1371/journal.pone.0086720.g002
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indicating a largely disordered structure in the Ct TDP-43
aggregates present in IBs.
The amide I region of the FTIR spectrum obtained with C43S
AcPDro2 IBs, used here as a positive control for bacterial IBs
containing amyloid-like aggregates, features a remarkable peak in
the b-sheet region, unlike the wt AcPDro2 IBs, indicating the
presence of a largely b-sheet structure in the C43S AcPDro2
aggregates (Fig. S2).
PK Digests FL TDP-43 and Ct TDP-43 Aggregates
Contained in IBs
PK is a protease usually used to map the protected core of
amyloid fibrils because it is highly active against peptide bonds of
globular and disordered proteins, but it cannot attack the highly
packed backbones in amyloid b-sheet structures [44]. Both FL
TDP-43 IBs and Ct TDP-43 IBs were treated with 20 mg/mL of
PK and their protein content was analysed using SDS-PAGE. At
this PK concentration a fast cleavage of FL TDP-43 was observed,
with its band disappearing after 5 min of incubation (Fig. 4A,B). A
Figure 3. Secondary structure analysis of FL TDP-43 IBs, Ct TDP-43 IBs and control IBs. CD spectra (A,B), amide I regions of FTIR spectra
(C,D) and second derivative of FTIR spectra (E,F) of FL TDP-43 IBs (A,C,E) and Ct TDP-43 IBs (B,D,F). In both analyses, the spectra are those of TDP-43 IBs
(green), control IBs (blue) and difference spectra obtained subtracting the latter from the former (red).
doi:10.1371/journal.pone.0086720.g003
TDP-43 Aggregates Are Amorphous and Cytotoxic
PLOS ONE | www.plosone.org 7 January 2014 | Volume 9 | Issue 1 | e86720
fast cleavage was also observed for Ct TDP-43 (Fig. 4C,D). In this
case the Ct TDP-43 band does not seem to disappear completely
after 20 min of incubation, but it is reasonable to assume that the
apparent remaining band was associated with an E. coli protein
present in IBs having a molecular weight superimposed to that of
Ct TDP-43 (compare Ct TDP-43 IBs and control IBs in Fig. 1C).
FL TDP-43 IBs were also treated with a higher PK concentration
(250 mg/mL), which induced a rapid disappearance after only
120 s (Fig. 4E,F). Other E. coli proteins present in TDP-43 IBs
were susceptible to the action of PK, but they were generally more
resistant, indicating the presence of amyloid-like structures in the
IBs (Fig. 4A–F). Thus, these data confirm further the absence of an
amyloid core in the FL TDP-43 and Ct TDP-43 aggregates
contained in IBs.
The higher PK concentration (250 mg/mL) was also utilized for
treating both FL TDP-43 IBs and control IBs and follow the
decrease in the turbidimetry signal at 350 nm (Fig. 4G). At time
zero the turbidimetry caused by FL TDP-43 IBs was greater than
that of control IBs, because of the 30% protein concentration
difference present in FL TDP-43 IBs relative to control IBs. A time
dependent decrease in the absorbance value was found to occur
for both FL TDP-43 IBs and control IBs, due to digestion of non-
amyloid aggregates. After 140 s the two curves were apparently
superimposable and reached gradually a plateau. This implies that
the FL TDP-43 aggregates were entirely digested by PK within
140 s, confirming the absence of a PK-resistant cross-b organiza-
tion in these aggregates.
FL TDP-43 IBs, Ct TDP-43 IBs and Control IBs Appear
Morphologically Irregular
AFM was used to investigate the morphology of FL TDP-43
IBs, Ct TDP-43 IBs and control IBs. All IBs samples appeared as
irregular structures with heights of 3362 nm for FL TDP-43 IBs
(Fig. 5A), 3663 nm for Ct TDP-43 IBs (Fig. 5B) and 3262 nm for
control IBs (Fig. 5C). Such structures were formed by a variable
number of disk or crescent-shaped subunits having a height of 7–
8 nm (Fig. 5A–C). After 1 h digestion with 20 mg/mL PK all IBs
were proteolysed and only a large number of small structures
having a height of , 3 nm remained in the samples (as exampled
by FL TDP-43 IBs digestion reported in Fig. 5D), possibly
representing small aggregates of the lipids and polypeptides that
are known to be present in bacterial IBs [45–47]. Interestingly, the
absence of fibrillar structures after PK treatment indicates that the
TDP-43 aggregates present in the IBs are not amyloid-like.
Moreover, although the ThT and CR assays, as well as CD and
FTIR spectra, show the existence of amyloid aggregates in both
FL TDP-43 IBs and Ct TDP-43 IBs and arising from non-TDP-43
proteins, AFM imaging after PK digestion reveals that such
structures are unstable and less packed and organized then the
known amyloid aggregates.
Transfected FL TDP-43 IBs are Toxic to Cultured Neuronal
Cells
FL TDP-43 IBs and control IBs were also tested for their ability
to cause cellular dysfunction in cultured neuroblastoma SH-SY5Y
cells. Both forms of IBs were used to transfect the cells by means of
the PULSin protein delivery reagent (Polyplus-transfection, Ill-
kirch, France), which contains a cationic amphiphilic molecule
thus facilitating the entry of the IBs in the cellular cytoplasm. In a
first experiment, carried out to verify directly the presence of the
FL TDP-43 IBs inside the cytoplasm following transfection, FL
TDP-43 IBs were labeled with 5-FITC and then used to transfect
the cells. The images obtained with confocal microscopy show the
presence of abundant exogenous TDP-43 aggregates in the
cytoplasm, indicating the high yield of FL TDP-43 IBs transfection
(Fig. 6A).
In another set of experiments, both FL TDP-43 IBs and control
IBs were used to transfect the cells and the presence of FL TDP-43
in the transfected cells was assessed using anti-TDP-43 polyclonal
antibodies. Untreated (non-transfected) cells showed the presence
of abundant TDP-43 in the nuclei, as expected for cells expressing
endogenous TDP-43 which has a nuclear localization signal
(Fig. 6B). Cells transfected with control IBs showed a similar high
abundance of endogenous TDP-43 in the nuclei, whereas cells
transfected with FL TDP-43 IBs showed a combination of nuclear
endogenous TDP-43 and exogenous cytoplasmic TDP-43 (Fig. 6B).
Cells were also transfected with R-PE, a green fluorescent protein
used as a positive control and indeed shown to be present
abundantly in the cytoplasm following transfection (Fig. 6B).
The viability of SH-SY5Y cells treated with FL TDP-43 IBs and
control IBs was assessed by measuring their ability to reduce
MTT, their levels of intracellular ROS and their caspase-3
activity. All such tests are widely used to assess the toxicity of TDP-
43 expressed in eukaryotic cell cultures [21,48,49]. In all such tests,
cells treated with control IBs were found to be less viable than
untreated cells, which are cells treated with the transfection mix
only (Fig. 6C–E). However, a significantly lower level of viability
was found in cells treated with FL TDP-43 IBs, showing that the
presence of FL TDP-43 in the IBs increases their toxicity (Fig. 6C–
E). Importantly, the FL TDP-43 concentration was 1.7 mg/mL in
the samples used to transfect the cells in all such tests, indicating
that the protein aggregated in the non-amyloid form described
above is highly toxic.
For the reasons explained above, the FL TDP-43 IBs contained
a total protein concentration higher by ca. 30% (5.7 mg/mL) than
that of control IBs (4.0 mg/mL). To assess whether the higher
toxicity observed for FL-TDP-43 IBs was due to its higher protein
content, the cells were also treated with control IBs containing a
total protein quantity similar to that of FL TDP-43 IBs (5.7 mg/
mL), but the FL-TDP-43 IBs still maintained a significantly higher
toxicity with all probes of cell viability (Fig. 6C–E). All the values of
toxicity reported here refer to cells transfected with the transfec-
tion mix only, ruling out that the observed toxicity of internalised
FL TDP-43 IBs originates from the transfection procedure.
Moreover, R-PE was not found to decrease significantly the
MTT reduction following transfection, ruling out that transfected
protein samples are per se toxic (Fig. 6C).
Transfected FL TDP-43 IBs are Partially Ubiquitinated and
Phosphorylated in Cultured Neuronal Cells
In order to assess whether the exogenous cytoplasmic FL TDP-
43 IBs were ubiquitinated, we analysed the colocalization of FL
TDP-43 IBs with ubiquitin. The images obtained with confocal
microscopy showed a weak and diffuse cytoplasmic ubiquitin
staining in the cytoplasm of SH-SY5Y cells transfected with
control IBs, whereas a marked staining and the presence of
inclusions was evident in cells transfected with FL TDP-43 IBs
(Fig. 7A). In particular, a partial colocalization between cytoplas-
mic TDP-43 IBs and ubiquitin was observed (Fig. 7A). To
investigate whether the exogenous cytoplasmic FL TDP-43 IBs
were phosphorylated, we employed antibodies that recognize
phosphorylated S409/410 in TDP-43 (Fig. 7B). The confocal
images showed a clear phosphorylation of FL TDP-43 IBs (Fig. 7B)
and these phosphorylated sites appeared to partially colocalize
with ubiquitin (Fig. 7B). All these data suggest that FL TDP-43 IBs
are partially ubiquitinated and phosphorylated, recapitulating
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major features of the endogenous cytoplasmic inclusions found in
ALS and FTLD-U.
The toxicity of FL TDP-43 IBs and control IBs was also assessed
in the presence of specific inhibitors of the proteasome,
authophagy and lisosomes systems, such as MG-132, 3-MA and
chloroquin, respectively (Fig. 7C). Cells treated with control IBs in
the presence of the three inhibitors were found to decrease MTT
reduction to a level similar to control IBs alone (Fig. 7C).
Interestingly, a significantly lower level of viability was found in
cells treated with FL TDP-43 IBs in the presence of MG-132 with
respect to cells treated with FL TDP-43 IBs alone, showing that
the inhibition of the proteasome system increases their toxicity
(Fig. 7C). The cells treated with FL TDP-43 IBs in the presence of
chloroquin also showed a significant decrease of cell viability with
respect to cells treated with FL TDP-43 IBs alone, whereas cell
treatment with FL TDP-43 IBs in the presence of 3-MA was not
found to modify cell viability to a significant extent (Fig. 7C).
These data indicate that the TDP-43 aggregates contained in FL
TDP-43 IBs are toxic to the transfected cells, which react to their
presence via mechanisms dedicated to the clearance of misfolded
proteins.
Extracellular FL TDP-43 IBs are Toxic to Cultured Neuronal
Cells
The toxicity of FL TDP-43 IBs and control IBs was also assessed
by adding them to the extracellular medium of the SH-SY5Y cells
in the absence of any transfection procedure. We first evaluated
the toxic effect of both forms of IBs by measuring the ability of
treated cells to reduce MTT (Fig. 8A). Their toxic effect was
analysed at different protein concentrations, ranging from 7.5 mg/
mL to 860 mg/mL (plus 30% for FL TDP-43 IBs). Ab42 oligomers
were also used as a positive control of toxicity in a range of
concentrations varying from 7.5 mg/mL to 215 mg/mL (Fig. 8A).
It was found that FL TDP-43 IBs, unlike control IBs, were able to
decrease MTT reduction at concentrations of 171 mg/mL or
higher (Fig. 8A). FL TDP-43 IBs were also found to cause an
increase of intracellular ROS production and caspase-3 activation,
whereas control IBs induced only small changes (Fig. 8B,C).
Discussion
In 2006 it was reported, for the first time, that ubiquitin-
positive, tau- and a-synuclein-negative intracellular inclusions
found in the spinal cord motor neurons, in the hippocampus and
neocortex of sporadic ALS and FTLD-U patients, contained the
previously unidentified TDP-43 protein or its C-terminal frag-
ments [4]. Such inclusions appear to be phosphorylated and
ubiquitinated [4,6,7], but the structure adopted by TDP-43 in
such deposits is currently a matter of debate. The IBs formed in E.
coli cells following the over-expression of TDP-43 are informative
in this regard, as bacterial IBs have been shown to consist mainly
of amyloid-like deposits, providing an opportunity to emphasize
the propensity of this protein to form amorphous aggregates if the
amyloid form is not found in the TDP-43 component of the IBs.
Our results indicate that both FL and Ct TDP-43 aggregates
present in E. coli IBs do not possess any of the hallmarks of amyloid
fibrils, allowing them to be classified as amorphous. CD and FTIR
both show the presence of a secondary random-coil and b-turn
structure in the absence of any detectable b-sheet structure. The
aggregates bind neither ThT nor CR and are highly susceptible to
PK digestion. The AFM analysis does not allow to visualize the
morphology of the TDP-43 aggregates within the IBs. However,
the IBs containing both FL and Ct TDP-43 appear to have an
irregular morphology like that of the control IBs devoid of TDP-
43.
The question naturally arises as to whether our findings resolve
the current dispute on the structural/morphological type of
inclusions present in TDP-43 pathology or rather add one more
contribution to the ongoing debate. In order to address this issue
we can try to survey the current literature critically. The first
reports aimed at characterizing the structure/morphology of
TDP-43 inclusions accumulating in ALS and FTLD-U patients
have excluded the presence of amyloid-like structures. Although
the ultrastructure of TDP-43 inclusions analysed with TEM have
highlighted the presence of 10–20 nm filaments [9,10,13–15], the
aggregates were found to be unable to bind ThT, ThS or CR,
ruling out the presence of an amyloid-like structure [11,16]. A very
recent report has emphasized that TDP-43 inclusions may consist
of amyloid fibrils, following the observation of a few ThS-positive
inclusions [13]. Nevertheless, the ThS positivity was found only in
a small fraction of skein-like inclusions of the spinal cord; it was
indeed absent in most spinal cord skeins and absent altogether in
other types of TDP-43 inclusions of the spinal cord [13]. All
inclusions of the brain were also ThS negative [13]. By contrast,
Figure 4. PK proteolysis of FL TDP-43 IBs, Ct TDP-43 IBs and control IBs. (A) SDS-PAGE of FL TDP-43 IBs after incubation with PK at the
indicated times. The temperature was 37uC, the total protein concentration of FL TDP-43 IBs was 14.3 mg/mL and the PK concentration was 20 mg/
mL. The band at , 69 kDa indicates GST/FL TDP-43. (B) Corresponding densitometric analysis graph of SDS-PAGE bands representing FL TDP-43
(green), proteins other than FL TDP-43 (red) and two E. coli proteins labeled P1 and P2 (blue and purple). (C) SDS-PAGE of Ct TDP-43 IBs after
incubation with PK at the indicated times. Conditions were as in panel A. The band at , 46 kDa indicates GST/Ct TDP-43. (D) Corresponding
densitometric analysis graph of SDS-PAGE bands representing Ct TDP-43 (green), proteins other than Ct TDP-43 (red) and two E. coli proteins labeled
P1 and P2 (blue and purple). (E) SDS-PAGE of FL TDP-43 IBs after incubation with PK at the indicated times. The temperature was 37uC, the total
protein concentration of FL TDP-43 IBs was 14.3 mg/mL and the PK concentration was 250 mg/mL. (F) Corresponding densitometric analysis graph of
SDS-PAGE bands representing FL TDP-43 (green), proteins other than FL TDP-43 (red) and two E. coli proteins labeled P1 and P2 (blue and purple). (G)
Kinetics at 37uC of PK digestion of FL TDP-43 IBs and control IBs monitored by turbidimetry at 350 nm. The total protein concentration for FL TDP-43
IBs and control IBs was 14.3 mg/mL and 10 mg/mL, respectively, and the PK concentration was 250 mg/mL.
doi:10.1371/journal.pone.0086720.g004
Figure 5. Morphology of FL TDP-43 IBs, Ct TDP-43 IBs and
control IBs observed with AFM. (A–C) FL TDP-43 IBs, Ct TDP-43 IBs
and control IBs, respectively. The scan size is 2 mm. (D) FL TDP-43 IBs
after 1 h incubation with 20 mg/mL PK. The scan size is 2 mm. The inset
shows a detail of the main panel at higher magnification (scan size
250 nm). In all panels left and right images represent height and
amplitude data, respectively. Z range: 130 nm (A), 100 nm (B), 90 nm
(C), 10 nm (D).
doi:10.1371/journal.pone.0086720.g005
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the most recent paper reporting a diffuse ThS positivity in all
TDP-43 inclusions analysed in ALS spinal cords and FTLD-U
brains raises important questions on the results obtained previ-
ously [12]. This study originated from a chemically harsh
treatment of the tissue sections isolated from ALS and FTLD-U
patients, based on the sequential use of potent oxidants,
reductants, acids and bases, such as permanganate, metabisulfite,
oxalic acid, sodium hydroxide and hydrogen peroxide, all known
Figure 6. Toxicity of FL TDP-43 IBs and control IBs delivered intracellularly. (A) Representative confocal scanning microscope images of SH-
SY5Y cells transfected with FL TDP-43 IBs labeled with 5-FITC. Red and green fluorescences indicate cell profiles and labeled FL TDP-43 IBs,
respectively; the images were analysed at median planes parallel to the coverslip. (B) Representative confocal scanning microscope images of SH-
SY5Y cells transfected with FL TDP-43 IBs, control IBs and R-PE. Red fluorescence indicates cells profiles and green fluorescence indicates TDP-43
detected with immunofluorescence or R-PE. (C) MTT reduction of SH-SY5Y cells following transfection with FL TDP-43 IBs (5.7 mg/mL), control IBs
(4.0 mg/mL and 5.7 mg/mL) and R-PE (4.0 mg/mL). (D,E) Representative confocal scanning microscope images of SH-SY5Y cells showing intracellular
ROS levels (D) and caspase-3 activation (E) after transfection with FL TDP-43 IBs (5.7 mg/mL) and control IBs (4.0 mg/mL and 5.7 mg/mL). The green
fluorescence arises from the CM-H2DCFDA probe that has reacted with ROS and from FAM-FLICA
TM Caspase 3&7. The histograms show the
quantitative fluorescence values in both cases. In panels C-E untreated cell means cells treated with the transfection mix only without proteins. The
double (**) and triple (***) asterisks refer to p values lower than 0.01 and 0.001, respectively.
doi:10.1371/journal.pone.0086720.g006
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to chemically modify proteins and hydrolyse peptide bonds. It
cannot be ruled out that the biological inclusions undergo a heavy
structural reorganization under such circumstances.
The difficulty of purifying TDP-43 has limited the study of
TDP-43 aggregation in vitro and is likely to be a limiting factor in
future research on TDP-43. One report exists, however, on the
characterization of the aggregates formed in vitro from TDP-43
after its purification [18]. This study has confirmed a filamentous
morphology of TDP-43 aggregates, in the absence of ThT and CR
binding [18]. By contrast, four other reports have emphasized an
amyloid-like structure of TDP-43 aggregates, but all of them have
referred to short peptides of 13 to 50 residues, all obtained from
the sequence of TDP-43 [19–22]. It is well known that protein
fragments have generally aggregation properties different from
those of the full-length protein and it was recently reported that
amyloid-like aggregation, as opposed to structurally undefined
aggregation, is favored by small peptides and proteins [50].
Hence, our data and analysis suggest that FL and Ct TDP-43
form amorphous aggregates rather than amyloid-like. The finding
that most, if not all, TDP-43 aggregates are amorphous in the
spinal cord and brain of ALS and FTLD-U patients, in bacterial
IBs and finally in aggregates formed in vitro from purified TDP-43,
suggests that this protein has an intrinsic propensity to form
amorphous aggregates and that such a propensity is not affected
remarkably by specific factors present in the biological compart-
ments where aggregation occurs.
The bacterial TDP-43 IBs characterized here were found to be
highly toxic to cultured neuronal cells, particularly following their
internalization in the cytoplasm, where they are at least in part
ubiquitinated and phosphorylated. A significant toxicity was found
using intracellularly delivered IBs where TDP-43 was present at a
concentration as low as 1.7 mg/mL before internalisation. It is
debated whether aggregation of TDP-43 in the cytoplasm of ALS
and FTLD-U patients causes neurodegeneration due to formation
of toxic protein aggregates (gain of function) or to the translocation
of TDP-43 from the nucleus, which represents its physiological
location, to the cytoplasm (loss of function), or both. Our results
show that delivery of exogenous TDP-43 into the cytoplasm occurs
in the absence of a significant loss of endogenous TDP-43 in the
nucleus. Indeed, the images acquired after delivery show
cytoplasmic TDP-43 in the absence of detectable clearance of
nuclear TDP-43. Thus, the non-amyloid, amorphous aggregates
formed from TDP-43 are inherently highly toxic to neuronal cells,
indicating that a gain of function mechanism caused by TDP-43
deposits is effective in such pathology. The data do not exclude
that a loss of function mechanism originating from the cellular
mistrafficking of TDP-43 also contributes to pathology, but shows
the inherent toxicity of TDP-43 aggregates.
In conclusion we have shown, using bacterial IBs containing
aggregated TDP-43 as a model system, that both FL and Ct TDP-
43 aggregates consist of non-amyloid assemblies that have an
intrinsically high ability to cause neuronal dysfunction when
delivered into the cytoplasm, contributing to elucidate the
pathogenesis of TDP-43 proteinopathies such as FTLD-U and
ALS.
Figure 7. Ubiquitination and phosphorylation of FL TDP-43 IBs
and control IBs delivered intracellularly. (A) Representative
confocal scanning microscope images showing partial colocalization
of exogenous cytoplasmic TDP-43 with ubiquitin-positive aggregates in
SH-SY5Y cells transfected with control IBs and FL TDP-43 IBs. Green and
red fluorescences indicate TDP-43 and ubiquitin, respectively. (B)
Representative confocal scanning microscope images showing partial
colocalization of phosphorylated S409/410 of TDP-43 and ubiquitin-
positive aggregates in SH-SY5Y cells transfected with control IBs and FL
TDP-43 IBs. Green and red fluorescences indicate pS409/410 TDP-43
and ubiquitin, respectively. (C) MTT reduction of SH-SY5Y cells following
transfection with FL TDP-43 IBs (5.7 mg/mL), control IBs (4.0 mg/mL) in
the absence or presence of 5 mM MG-132, 10 mM 3-MA and 40 mM
chloroquin. The single (*) and triple (***) asterisks refer to p values lower
than 0.05 and 0.001, respectively.
doi:10.1371/journal.pone.0086720.g007
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Supporting Information
Figure S1 CR and ThT binding of wt AcPDro2 IBs and
C43S AcPDro2 IBs. (A) Absorbance spectra of wt AcPDro2
IBs+CR (solid line), CR (dashed line) and wt AcPDro2 IBs (dotted
line). (B) Absorbance spectra of C43S AcPDro2 IBs+CR (solid
line), CR (dashed line) and C43S AcPDro2 IBs (dotted line). (C)
Difference absorbance spectra obtained for wt AcPDro2 IBs (blue)
and C43S AcPDro2 IBs (red). (D) ThT fluorescence spectra in the
presence of wt AcPDro2 IBs (blue) and C43S AcPDro2 IBs (red).
The CR and ThT analyses show that IBs containing the
destabilised and amyloidogenic C43S mutant of AcPDro2 bind
CR and ThT more markedly than IBs formed after expression of
the less stable and less amyloidogenic wt AcPDro2. The C43S
AcPDro2 IBs, therefore, can act as a positive control showing the
presence of amyloid-like aggregates in IBs arising from the
expressed protein.
(TIF)
Figure S2 Amide I regions of FTIR spectra of wt
AcPDro2 IBs (blue) and C43S AcPDro2 (red). The analysis
shows that IBs containing the destabilised and amyloidogenic
C43S mutant of AcPDro2 have a large amount of b-sheet
structure with respect to IBs formed after expression of the less
stable and less amyloidogenic wt AcPDro2. The C43S AcPDro2
IBs, therefore, can act as a positive control showing the presence of
amyloid-like aggregates in IBs arising from the expressed protein,
confirming the CR and ThT analyses.
(TIF)
Methods S1 Description of the methods involving
preparation and analysis of wt AcPDro2 IBs and C43S
AcPDro2 IBs.
(DOC)
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